Finance

Lists
8C5:FRA
Coherus Oncology Inc
€1.21
+3.61%
(+0.042) 1D
Sep 3, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 8C5...
Open
€1.21
High
€1.21
Low
€1.21
Mkt. cap
211.67M
Avg. vol.
0.00
Volume
0.00
52-wk high
€2.19
52-wk low
€0.94
No. of employees
144
Open
€1.21
High
€1.21
Low
€1.21
Mkt. cap
211.67M
Avg. vol.
0.00
Volume
0.00
52-wk high
€2.19
52-wk low
€0.94
No. of employees
144
About Coherus Oncology Inc
CEODennis Lanfear
Employees144
Founded2010
HeadquartersRedwood City, California, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
11.57M
12.75M
12.31M
14.31M
Cost of goods sold
3.72M
4.04M
3.81M
4.24M
Cost of revenue
3.72M
4.04M
3.81M
4.24M
Research and development expenses
27.25M
30.97M
21.54M
21.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
22.83M
21.01M
23.10M
20.95M
Operating expense
50.08M
51.98M
44.65M
42.40M
Total operating expenses
53.80M
56.03M
48.46M
46.64M
Operating income
-42.23M
-43.28M
-36.15M
-32.33M
Other non operating income
2.14M
-5.22M
1.40M
1.31M
EBT including unusual items
-44.52M
-46.35M
-36.94M
-33.35M
EBT excluding unusual items
-42.42M
-43.75M
-36.94M
-33.35M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-35.53M
-37.64M
-38.33M
-20.63M
Net profit margin
-307.07%
-295.29%
-311.35%
-144.20%
Earnings per share
-0.33
-0.34
-0.25
-0.19
Interest and investment income
-
7.00M
-
-
Interest expense
-2.32M
-2.25M
-2.19M
-2.32M
Net interest expenses
-2.32M
4.75M
-2.19M
-2.32M
Depreciation and amortization charges
-
-
-
-
EBITDA
-41.27M
-42.38M
-35.27M
-31.47M
Gain or loss from assets sale
-
-338.32M
-
-
AI content may include mistakes. Learn more
Google apps